Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Tagrisso (osimertinib) Disease area(s): Oncology Manufacturer(s): AstraZeneca 2024 Sales (USD): $6.58 billion Why it sold so well: In 2024, AstraZenecas EGFR-TKI Tagrisso registered $6.58 billion in global sales, reflecting a 13% year-over-year increase
Every lot is assayed by an independent laboratory and the certificate is published before the compound is listed
Not a magic pill These medications are designed to be taken alongside weight-loss interventions to improve your lifestyle and shouldnt be considered lifelong medications
Worked as advertised I have only been on this for a month and have lost 10lbs already
It works by supporting the bodys natural signaling related to growth hormone pathways (rather than replacing growth hormone directly)
US$ 29.66
US$ 26.74
US$ 26.85
US$ 25.95
